ARTICLE | Company News
ImaginAb, Oxford BioMedica deal
June 13, 2011 7:00 AM UTC
Oxford BioMedica and ImaginAb partnered to engineer an in vivo diagnostic imaging agent using an antibody that targets Oxford's 5T4 tumor antigen through proof of concept (POC). Following POC, Imagin...